Evidence Framework

Three Evidence Pillars

PoC

Long‑term PoC with Eisai Korea confirmed engagement and consistent cognitive improvement in everyday settings, demonstrating real‑world efficacy.

Clinical

Clinical research conducted by Ewha Womans University Mokdong Hospital (EUMC) medically validated both the cognitive improvement effects and safety for older adults.

Academic

The research findings were published as a peer‑reviewed paper in the international journal Psychiatry Investigation, establishing global academic credibility.

Three Layers of Scientific Evidence

Three Layers of Scientific Evidence Supporting FunXingQ

Real‑World Demonstration (PoC)

100%

Clinical Validation

100%

Academic Evidence

100%
Proof of Concept (PoC)

PoC: Real‑World Demonstration

  • Implementing Organizations:

    Eisai Korea and senior care facilities

  • PoC Phases:

    Phase 1 to 3

  • Implementation Period:

    2022–2024

PoC Summary

FunXingQ conducted a three‑year, multi‑phase PoC in collaboration with Eisai Korea and multiple senior welfare facilities. In Phase 1, 34 active seniors in their 50s–70s used the tablet version for three months, recording 519 total hours of use and an average of two hours per day. From week four onward, improvements in problem‑solving ability and digital device adaptation were observed. In Phase 2, 89 older adults (70s–90s) across seven facilities used the table‑type device, with all sites showing increases in both usage frequency and duration. Cognitive test scores also improved, and experts evaluated the program as “a new community‑linked model for digital cognitive education.” In Phase 3, 584 participants across 42 facilities used the individual version for four months, resulting in a five‑fold increase in total usage time. CogMate assessments showed improvements in attention (+3.4), memory (+0.9), and a reduction in brain age (−1.5 years). Together, these results demonstrate FunXingQ’s real‑world viability—sustained engagement, reproducible cognitive improvement, and strong applicability across administrative, medical, and welfare settings.

Clinical Trial

Clinical Validation

  • Implementing Organizations:

    Ewha University Mokdong Hospital

  • Study Type:

    Clinical Study

  • Implementation Period:

    2022–2024

Clinical Trial Summary

FunXingQ underwent a clinical study at Ewha Womans University Mokdong Hospital (EUMC), where its cognitive improvement effects and safety were medically verified. The study evaluated how FunXingQ’s training influences everyday cognitive processing in cognitively healthy older adults. Eight cognitive domains were assessed, covering both left‑brain logical functions—abstraction, reasoning, analysis, and decision‑making—and right‑brain visuospatial and integrative functions such as spatial reasoning, constructional ability, processing speed, and visual‑perceptual insight. These domains align with the higher‑order cognitive processes FunXingQ has emphasized since its design stage, including problem‑solving, visuospatial processing, and information integration. Results showed improvement trends across multiple cognitive areas, with notable gains in problem‑solving, sustained attention, and visuospatial processing—abilities directly linked to daily decision‑making and situational awareness. Participants also demonstrated strong adherence and adaptability, confirming the usability of the training program. No safety concerns were observed throughout the study period, and the program was evaluated as a safe digital cognitive training solution suitable for use in medical settings. These findings position FunXingQ as a clinically validated cognitive enhancement solution for healthcare environments.

Peer‑Reviewed Academic Publication

International Academic Paper

  • Research Institutions:

    EUMC / Ewha Womans Univ.
    School of Medicine & AI Convergence

  • Study Type:

    Peer‑Reviewed Publication

  • Study Period:

    2024.08–2024.11

Academic Validation through Peer‑Reviewed Publication (Published in Psychiatry Investigation)

Using clinical trial data from EUMC, the research team reanalyzed the results as a randomized controlled trial (RCT), and the findings were published in the international peer‑reviewed journal Psychiatry Investigation. The study involved 40 cognitively healthy older adults who were assigned to either a 10‑week tablet‑based cognitive training group or a passive control group. Neurophysiological changes were assessed using quantitative EEG, and cognitive performance was evaluated using CANTAB. EEG analyses showed significant increases in absolute power across beta1–3, theta, and gamma bands in frontal and central regions, along with strengthened functional connectivity in fronto‑temporal and occipital networks—indicating enhanced neural efficiency and network integration. Cognitive assessments revealed significant improvements in memory‑related tasks such as Delayed Matching to Sample, Paired Associates Learning, and Pattern Recognition Memory. While attention and executive domains showed limited change, the memory‑specific enhancement was clear and consistent. This study provides early international evidence that tablet‑based digital cognitive training can induce neurophysiological changes and improve memory function in older adults, academically supporting FunXingQ’s potential to enhance cognitive resilience as a non‑pharmacological intervention.

Evidence‑Based Cognitive Wellness.